Arterial Dynamic Elastance in ICU Patients on Inotropic or Vasopressor Drugs
The study aims to assess changes in dynamic arterial elastance in ICU patients receiving inotropic or vasopressor drugs as displayed on a hemodynamic monitor.
dobutamine
+ norepinephrine
Infections+3
+ Inflammation
+ Pathologic Processes
Diagnostic Study
Summary
Study start date: March 31, 2019
Actual date on which the first participant was enrolled.This study focuses on assessing the cardiovascular health and blood flow dynamics in patients who are in Intensive Care Units (ICU) and depend on drugs that support heart function or blood pressure. These drugs, known as inotropes and vasopressors, help the heart pump more effectively or raise blood pressure. The aim is to understand how these patients' hearts and blood vessels respond to treatment by monitoring changes in blood flow and pressure. By doing so, the study hopes to improve patient care by optimizing how fluids and medications are administered, particularly in critical conditions where the heart and blood circulation are compromised. Participants in this study will undergo monitoring that combines blood pressure readings with tools that measure how much blood the heart pumps. This monitoring can be done using devices that might either be placed on the skin or require a small procedure to place them inside the body. The study evaluates a measurement called dynamic arterial elastance, which helps understand the relationship between changes in blood pressure and blood flow during each heartbeat. The results will be captured on a hemodynamic monitor, which provides real-time feedback to help adjust medical care. This approach aims to tailor treatment for better clinical outcomes in ICU settings.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Diagnostic Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 75 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Group II
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location